Karen Read's case returned to court Tuesday with a harsh warning for her defense team and a long to-do list as attorneys prepare for the start of her second trial ...

The shots of espresso inside Flamingos Coffee Bar are caffeine-filled pick-me-ups, but the vibe inside the Exeter coffee shop is just as uplifting. "Something fun and vibrant, a place where you can ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

Jason Kidd did not provide any additional details on Olivier-Maxence Prosper’s wrist sprain, which will reportedly require ...

In my eyes, as a proud Irishman, one of the biggest flaws this country has is the inability to stock quality Irish products.

Oxbryta came to market in 2019, a few days after Novartis' injectable anti-P-selectin antibody Adakveo (crizanlizumab), which is also tipped for blockbuster sales but like Oxbryta has suffered ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed ...

Here the authors show that in response to bile acid chenodeoxycholic acid during cholestasis, endothelial Myc activation triggers P-selectin expression, promoting neutrophil infiltration and liver ...

Research analysts at StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology ...

In a media interview on March 12, Joshua Kimmich expressed heartfelt support for his midfield partner Leon Goretzka's potential return to the German national football team. His comments have stirred ...